Health Care & Life Sciences – Page 119 – Indianapolis Business Journal

PANEL: Life sciences will see radically different future

May 13, 2013

IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues of venture capital, digital health innovations and research university entrepreneurship.

Panel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.

The following is an unedited transcript of the discussion.

Lilly stops development on cancer drug after failed study

May 10, 2013

The drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual sales by 2018.

Truck insurer’s new jobs to boast gold-plated pay

May 9, 2013

The 133 full-time jobs the truck and auto insurer plans to add over the next five years will pay around $60 an hour, or nearly $125,000 a year.

Ruling keeps church ensnared in life insurance nightmare

May 9, 2013

A federal bankruptcy judge has slapped down an Anderson church that attempted to blame its bank for a failed scheme to finance church upgrades by buying life insurance policies on its elderly members.

Warner Transitional Services to close, lay off 112

May 8, 2013

Warner relies on funds from the Indiana Family and Social Administration, but the FSSA recently decided to end that funding after numerous complaints against the company went unresolved.

Governor taps ex-WellPoint CEO Braly for IEDC board

May 7, 2013

The appointment is the first high-profile post that Braly, 51, has accepted since she was ousted from the top spot at the Indianapolis-based health insurer in August.

Lilly CEO to step down temporarily due to surgery

May 6, 2013

John Lechleiter has been suffering from a dilated aorta, Eli Lilly and Co. said Monday. Current CFO Derica Rice will take his place until later this summer.

Biosciences institute aims for $300M endowment

May 6, 2013

The effort to launch the Indiana Biosciences Research Institute got $25 million from the Legislature, but the life sciences institutions backing the effort have set their funding sights much higher.

Lilly’s sales-force restructuring to affect 1,600-plus

May 6, 2013

Lilly will eliminate 1,624 positions from its U.S. sales force in July, according to a notice the company made to state officials. But some of those workers may be rehired by the firm.

Lilly taking hard look at Pfizer’s new Viagra strategy

May 6, 2013

Major drugmakers, including Indianapolis-based Eli Lilly and Co., are closely watching Pfizer Inc.’s plan to sell Viagra directly to consumers. The bold move blows up the drug industry’s distribution model.

New seed fund aims to make Indiana a hotbed for digital health startups

May 2, 2013

Infuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.

Medicaid expansion in Pence’s hands after session

May 1, 2013

The question of whether Indiana will expand Medicaid is now back in Gov. Mike Pence's hands, after lawmakers wrapped up their session without mandating he expand coverage under the federal health care law or suggesting the route he should take.

Lawmakers pass Medicaid ball back to Pence

April 29, 2013

After a four-month debate, the Legislature ended pretty much where it started on a potential expansion of Medicaid: Lawmakers are letting Gov. Mike Pence go one-on-one with President Obama to see what kind of deal he can strike.

Obamacare exchanges could zap WellPoint profits

April 29, 2013

According to one estimate, the Indianapolis-based health insurer will shed $400 million in pre-tax profits by 2017.

Anti-smoking officials say Indiana funding cuts hurt

April 27, 2013

A decision to cut state funding by 38 percent for programs that help people stop smoking and try to prevent others from starting worries those behind the state's tobacco cessation efforts.

Feds scrutinize nursing home buying spree

April 25, 2013

Indiana’s county-owned hospitals have rushed to acquire nursing homes in the past two years, opening a revenue stream for both the hospitals and the long-term-care facilities. But the additional federal revenue that has driven these purchases could come under threat.

Lilly suing J&J for patent rights in Alzheimer’s drug race

April 25, 2013

Eli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay availability of a potential treatment for Alzheimer’s disease.

WellPoint CEO: Acquisitions of hospitals, doctors unlikely

April 24, 2013

Joe Swedish, who took the helm of the Indianapolis-based health insurer a month ago, threw cold-water Wednesday on widespread speculation that he will lead the company through a wave of buying hospitals and medical practices.

Eli Lilly’s profit shoots up despite lackluster sales

April 24, 2013

The Indianapolis pharmaceutical company left its full-year profit forecast unchanged despite a spike in first-quarter earnings. Revenue fell short of analyst expectations.

WellPoint raises profit forecast after solid first quarter

April 24, 2013

The Indianapolis-based health insurer easily beat Wall Street’s expectations for earnings in the first quarter and revenue rose 15 percent.

Articles